Prosecution Insights
Last updated: April 19, 2026

Recode Therapeutics Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
4
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18420141 POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF HAGHIGHATIAN, MINA 1616 Final Rejection Jan 23, 2024
18282699 POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF HAGHIGHATIAN, MINA 1616 Final Rejection Sep 18, 2023
18282181 POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF KONOPKA, CATHERINE ANNE 1635 Non-Final OA Sep 14, 2023
18312305 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS SHIN, DANA H 1635 Final Rejection May 04, 2023
18311274 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS HAGHIGHATIAN, MINA 1616 Final Rejection May 03, 2023

Managing Recode Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month